Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
Completed · Phase 3
Conditions studied: Cancer
In brief
RATIONALE: Captopril may protect the lungs from the side effects of bone marrow or stem cell transplantation. PURPOSE: Randomized phase III trial to determine the effectiveness of captopril to lessen the side effects in patients who are undergoing bone marrow or stem cell transplantation following chemotherapy and radiation therapy.
Key facts
- Study ID
- NCT00004230
- Run by
- Northwestern University
- People needed
- 35
- Starts
- 1999-10-01
- Expected to finish
- 2002-03-01
- Last updated by the study team
- 2012-06-06
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.